FDA Panel Votes in Favor of Pfizer Covid-19 Vaccine for Children Aged 5 – 11

“In a 17-0 vote, the US Food and Drug Administration (FDA) has recommended that the agency authorize the emergency use of Pfizer-BioNTech COVID-19 vaccine for children ages 5 through 11.”

With virtually a 100% survival rate, kids receive no benefit from the jab and will incur all the risks, which we know are substantial. But this does not need to be repeated…it just doesn’t matter to those making these decisions…the plan to inject everyone must move forward.

FDA Panel Votes In Favor Of Pfizer Covid-19 Vaccine For Children Aged 5 – 11 | ZeroHedge

Published by markskidmore

Mark Skidmore is Professor of Economics at Michigan State University where he holds the Morris Chair in State and Local Government Finance and Policy. His research focuses on topics in public finance, regional economics, and the economics of natural disasters. Mark created the Lighthouse Economics website and blog to share economic research and information relevant for navigating tumultuous times.

Leave a Reply

%d bloggers like this: